Cell and gene therapy is an exciting and rapidly evolving area of development in the life sciences sector. These treatments can be life changing and potentially lifesaving for patients with rare diseases, and severe conditions. However, the cost of innovative treatments creates a challenge for the health system and requires new pathways to support access.

Develop a strategic plan for your product and minimize hurdles with insights on:

• Obstacles to adoption, implementation, and financing of testing technology
• Navigating Canada’s regulatory and HTA pathways for cell and gene therapy
  • Building data to support decision making on cell and gene therapies
• Gaps in reimbursement infrastructure for complex gene therapies
  • Exploring opportunities for innovative agreements